[1]
2022. Evaluation of Intra-Arterial Nimodipine Therapy in Post-Subarachnoid Hemorrhage Refractory Cerebral Vasospasm. Cardiology and Cardiovascular Medicine. 6, 4 (Jul. 2022), 383–389.